Aliment Pharmacol Ther

1. WANG R, Wu Y, Xu D, Yang Y, et al
   Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulizing Crohn's Disease.
   Aliment Pharmacol Ther. 2026 Mar 3. doi: 10.1111/apt.70600.
   

   >> Share

   
   

   
   BMC Gastroenterol

2. HUANG M, Huang S, Luo Q, Zheng Y, et al
   Development and validation of a model incorporating choroid plexus morphology from brain MRI to predict anti-TNF-alpha therapy outcomes in Crohn's disease.
   BMC Gastroenterol. 2026 Mar 6. doi: 10.1186/s12876-026-04720.
   

   >> Share

   
   

   
   Dig Dis Sci

3. SUTTON S, Voskamp S, Le K, Hafez A, et al
   Malondialdehyde Drives a Feed-Forward Reactive Oxygen Species Loop in Pediatric Crohn's Disease.
   Dig Dis Sci. 2026 Mar 6. doi: 10.1007/s10620-026-09796.
   

   >> Share

   
   
4. UCHITEL Y, Cohen NA, Hirsch A, Tulchinsky H, et al
   Comparative Effectiveness of Biologic Therapies in Chronic Pouchitis and Crohn's-Like Disease of the Pouch: A Bi-center Retrospective Cohort Study.
   Dig Dis Sci. 2026 Mar 5. doi: 10.1007/s10620-026-09804.
   

   >> Share

   
   
5. MAAS L, Lazarev M
   Muscle Matters: Sarcopenia, Visceral Adiposity, and Outcomes of Acute Severe Ulcerative Colitis.
   Dig Dis Sci. 2026 Mar 4. doi: 10.1007/s10620-026-09791.
   

   >> Share

   
   
6. GOLDOWSKY A, Eidelberg A, Geeganage G, Gade A, et al
   Sexual Health and STI Counseling Is Critical but Often Overlooked in IBD.
   Dig Dis Sci. 2026;71:457-465.
   

   >> Share

   
   

   
   Eur J Gastroenterol Hepatol

7. GUIMARAES A, Caetano AC, Barbosa I, Costa D, et al
   Validation of the Urgency Numeric Rating Scale and correlation with endoscopic, histological, and manometric activity in ulcerative colitis.
   Eur J Gastroenterol Hepatol. 2026 Feb 10. doi: 10.1097/MEG.0000000000003155.
   

   >> Share

   
   
8. ANANDABASKARAN S, Liu Z, Hanna L, Lung P, et al
   Tissue penetration of anti-tumour necrosis factor therapy in perianal fistulising Crohn's disease: a proof-of-concept study.
   Eur J Gastroenterol Hepatol. 2026 Feb 24. doi: 10.1097/MEG.0000000000003169.
   

   >> Share

   
   

   
   Gastroenterol Hepatol

9. FERREIRO-IGLESIAS R, Hernandez-Camba A, Valdivia A, Rodriguez-Lago I, et al
   Vaccination recommendations and adherence in Inflammatory Bowel Disease: a physician-patient discordance study.
   Gastroenterol Hepatol. 2026 Mar 2:502714. doi: 10.1016/j.gastrohep.2026.502714.
   

   >> Share

   
   

   
   Gastroenterology

10. COLOMBEL JF, Garcia Olmo D, Chen ST, Serclova Z, et al
    Darvadstrocel in Patients With Crohn's Disease With Complex Perianal Fistulas: The ADMIRE CD II Phase 3 Randomized Trial.
    Gastroenterology. 2026 Mar 6:S0016-5085(26)00024.
    

    >> Share

    
    

    
    Gut

11. HENS B, D'Haens G, Ungaro RC, Colombel JF, et al
    Screening for preclinical Crohn's disease based on capsule endoscopy is not yet ready.
    Gut. 2026 Mar 2:gutjnl-2026-338303. doi: 10.1136/gutjnl-2026-338303.
    

    >> Share

    
    

    
    Inflamm Bowel Dis

12. NARDONE OM, Calabrese G, Ford AC, Castiglione F, et al
    Prevalence of disability in inflammatory bowel disease: a systematic review and meta-analysis.
    Inflamm Bowel Dis. 2026 Mar 5:izag022. doi: 10.1093.
    

    >> Share

    
    
13. QURAISHI MN, Alahmad MA, Swaid TK, Facciorusso A, et al
    Incidence of acne in patients with inflammatory bowel disease treated with Janus kinase inhibitors: a systematic review and meta-analysis.
    Inflamm Bowel Dis. 2026 Mar 5:izag032. doi: 10.1093.
    

    >> Share

    
    
14. FENG T, Qiu Y, Chen B, Huang X, et al
    Mesenchymal stem cell-derived exosomes derived from induced pluripotent stem cells ameliorate inflammation and promote mucosal healing via miR-34a-5p in Crohn disease.
    Inflamm Bowel Dis. 2026 Mar 3:izag014. doi: 10.1093.
    

    >> Share

    
    

    
    J Crohns Colitis

15. GIUSTO EA, Pinton P, Giorgi C, Serino G, et al
    Risk of intestinal cancer in Crohn's disease: re-analysis and meta-regression of population-based cohort studies.
    J Crohns Colitis. 2026;20:jjag013.
    

    >> Share

    
    
16. MATELLAN C, Raphael B, Jones GR, Nwaeziegwe M, et al
    TWEAK is increased in ulcerative colitis and contributes to fibroblast-mediated monocyte activation via heterologous non-canonical NF-kB/STAT3 signaling.
    J Crohns Colitis. 2026;20:jjag012.
    

    >> Share

    
    

    
    Mediators Inflamm

17. HEYDARI R, Tavassolifar MJ, Nazari MHD, Roshannia R, et al
    TUG1 and H19 lncRNAs Can Predict Anti-TNF Unresponsiveness in Patients With Ulcerative Colitis: A Machine Learning-Based Approach.
    Mediators Inflamm. 2026;2026:9078048.
    

    >> Share

    
    

    
    PLoS One

18. XU T, Yao T, Chen Y, Xu F, et al
    Serum biomarkers for predicting Crohn's disease activity: The role of bilirubin, uric acid, and the C-reactive protein/albumin ratio.
    PLoS One. 2026;21:e0333855.
    

    >> Share

    
    
19. LIU X, Qingzhuoga D, Xiong D, Wang L, et al
    Phthalates exposure and serum uric acid level in patients with Crohn's disease: A cross-sectional study.
    PLoS One. 2026;21:e0343097.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share